SCN2A and pulmonary arterial hypertension: Severe cognitive impairment occurred in patients with mutations in NKX6-2, PLP1, PAH gene (when untreated), and SCN2A (in early-onset type), whereas milder ID was associated with SCN2A (in late-onset type) or SMAD6 variants.